RadNet, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
RadNet, Inc. (RDNT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 2.27% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2020-03-16
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2019 was 2.27%, a 89.17% increase from fiscal 2018.
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2018 was 1.20%, a 242.86% increase from fiscal 2017.
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2017 was 0.35%.
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2016 was -0.09%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2019-12-31 | 2.27% 10-K · filed 2020-03-16 | |
| 2018-12-31 | 1.20% 10-K · filed 2020-03-16 | |
| 2017-12-31 | 0.35% 10-K · filed 2020-03-16 | |
| 2016-12-31 | -0.09% 10-K · filed 2019-03-18 | |
| 2015-12-31 | -0.01% 10-K · filed 2018-03-19 | |
| 2014-12-31 | 0.00% 10-K · filed 2017-03-17 | |
| 2013-12-31 | 0.07% 10-K · filed 2016-03-15 | 2.05% 10-K · filed 2014-03-17 |
| 2012-12-31 | -2.42% 10-K · filed 2015-03-16 | -1185.45% 10-K · filed 2013-03-18 |
| 2011-12-31 | 4.97% 10-K · filed 2014-03-17 | 10.35% 10-K · filed 2013-03-18 |
| 2010-12-31 | -4.68% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |